Thyroid disease in relation to pregnancy: A decade of change

Clinical Endocrinology

Volumn 53, Issue 3, 2000, Pages 265-278

  Lazarus, John H ^a   Kokandi, Amal ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; THYROID ANTIBODY;

COMORBIDITY; FETOPLACENTAL UNIT; HELPER CELL; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNE RESPONSE; IMMUNOLOGY; KILLER CELL; PREGNANCY; PRIORITY JOURNAL; REVIEW; THYROID DISEASE; THYROID FUNCTION; TROPHOBLAST;

ABORTION, SPONTANEOUS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHORIONIC GONADOTROPIN; DEVELOPMENTAL DISABILITIES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOGLOBULINS, THYROID-STIMULATING; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS; THYROID DISEASES; THYROID GLAND; THYROXINE; TROPHOBLASTS;

EID: 0033824362     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01087.x     Document Type: Review

References (151)

1. The sonographic appearances in postpartum thyroiditis
2. Pregnancy suppresses the development of mouse thyroiditis by enhancing TH2 responses
3. Interleukin-6 levels are not increased in women with postpartum thyroid dysfunction
4. Transient postpartum hypothyroidism: Fourteen cases with autoimmune thyroiditis
5. Transient hypothyroidism after delivery in autoimmune thyroiditis
6. Postpartum autoimmune thyroid syndrome: A model of aggravation of autoimmune disease
7. Therapeutic controversy. Screening for postpartum thyroiditis
8. Thyroid size and thyroid function during pregnancy: An analysis
9. Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism
10. The transfusion immunomodulation theory: The Th1/Th2 paradigm and an analogy with pregnancy as a unifying mechanism
11. Postpartum flare in MRL-1pr mice is associated with a parallel increase of N-acetylglucosamine on serum IgG
12. Maternal thyroid function: Interpretation of thyroid function tests in preganancy
13. Changes in immune activation markers during pregnancy and postpartum
14. Maternal and fetal thyroid function
15. Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions
16. HLA-G revisited
17. Thyroid cancer in pregnant women: Diagnostic and therapeutic management
18. Methimazole embryopathy: Delineation of phenotype
19. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia
20. The iodide perchlorate discharge test in women with previous post-partum thyroiditis: Relationship to sonographic appearance and thyroid function
21. Interleukin 1 receptors in the brain and endocrine tissues
22. The thyroid immunology of the postpartum period
23. Iodine deficiency disorders in Europe
24. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero
25. Paternal leukocytes selectively increase secretion of IL-4 in peripheral blood during normal pregnancies: Demonstrated by a novel one-way MLC measuring cytokine secretion
26. Thyroid autoantibodies are not associated with recurrent pregnancy loss
27. Radioiodine treatment in unsuspected pregnancy
28. Maternally transferred thyroid diseaes in the infant: Recognition and treatment
29. Identification of a new thyrotropin receptor germline mutation (leu629 phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism
30. Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: A prospective study
31. Postpartum thyroid dysfunction in Mid Glamorgan
32. The presence of antithyroid antibodies in euthyroid patients with unexplained infertility and tubal obstruction
33. Postpartum transient thyrotoxicosis with painless thyroiditis
34. The regulation of thyroid function in pregnancy: Pathways of endocrine adaptation from physiology to patholgy
35. Pregnancy in patients with mild thyroid abnormalities: Maternal and neonatal repercussions
36. Goiter and pregnancy: A new insight into an old problem
37. Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves' disease patients: A sequential study before, during and after pregnancy
38. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum
39. Radioiodine and pregnancy
40. Severe congenital hyperthyroidism caused by a germ-line mutation in the extracellular portion of the thyrotropin receptor
41. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child
42. Pregnancy and autoimmune endocrine disease
43. Diagnosis and management of Graves' disease in pregnancy
44. Transient post-partum thyroid dysfunction and postnatal depression
45. Association between postpartum thyroid dysfunction and thyroid antibodies and depression
46. Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease
47. Nodular thyroid disease diagnosed during pregnancy: How and when to treat
48. Treatment of hyperthyroidism by radioactive iodine. Summary of a UK National Survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes
49. Coexistent thyroid cancer and pregnancy
50. Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy
51. Variation in the thyrotropic activity of human chorionic-gonadotropin in Chinese-hamster ovary cells arises from differential expression of the human thyrotropin receptor and microheterogeneity of the hormone
52. Prediction of postpartum onset of rheumatoid arthritis
53. Changes of lymphocyte subsets in normal pregnant and postpartum women: Postpartum increase of NK/K (Leu 7) cells
54. The maternal immune system in health and disease
55. Interference in thyroid function tests in postpartum thyroiditis
56. Propylthiouracil in human milk revision of dogma
57. Pregnancy and the thyroid
58. Gestational thyrotoxicosis and hyperemesis gravidarum: Possible role of hCG with higher stimulating activity
59. Pregnancy: A clue to normal regulation of B lymphopoisis
60. Prevalence of thyroid deficiency in pregnant women
61. Immune response in anti-TPO positive pregnant women antenatally and during postpartum period. British Endocrine Societies 2000
62. Enhanced phagocytosis of mononuclear phagocytes in pregnancy
63. Cell-mediated immunity and postpartum thyroid dysfunction: A possibility for the prediction of disease?
64. Prediction of postpartum thyroid dysfunction: Can it be improved?
65. A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy
66. Congenital hypothyroidism: Etiologies, diagnosis, and management
67. Graves' disease in the neonatal period and childhood
68. Guidelines for TSH-receptor antibody measurements in pregnancy; results of an evidence-based symposium organized by the European Thyroid Association
69. Treatment of hyper- and hypothyroidism in pregnancy
70. The effect of anti-TPO antibodies on thyroid function in early gestation: Implication for screening
71. Clinical aspects of recurrent postpartum thyroiditis
72. The clinical spectrum of postpartum thyroid disease
73. Prevention and treatment of postpartum Graves' disease
74. Autoimmune thyroiditis: Repercussions during and after pregnancy
75. Thyroid disease in relation to pregnancy
76. Postpartum thyroiditis
77. Antithyroid drugs underlying thyroid abnormalities and miscarriage or pregnancy induced hypertension
78. Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas
79. PAXS mutations associated with congenital hypothyroidism caused by thyroid dysgenesis
80. Maternal hypothyroxinemia: Psycho-neurological deficits of progeny
81. Review of antithyroid drug use during pregnancy and report of case of aplasia cutis
82. Increased need for thyroxine during pregnancy in women with primary hypothyroidism
83. Characterisation of type 1 and type 2 cytokine production profile in physiologic and pathologic pregnancy
84. Increased numbers of circulating interferon and interleukin-4-secreting cells during normal preganancy
85. Hyperthyroidism in pregnancy, diagnosis and treatment
86. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies
87. Antithyroid drug treatment of Graves' disease in pregnancy: Long-term effects on somatic growth, intellectual development and thyroid function of the offspring
88. Hyperthyroidism in pregnancy
89. Low birth weight and pre-eclampsia in pregnancies complicated by hyperthyroidism
90. Postpartum thyroiditis - A clinical, histologic and immunologic study of 15 cases
91. Effects of antithyroid drags on fetal thyroid function during the treatment of pregnant hyperthyroid women
92. Recovery from fetal hypothyroidism: Evidence for the safety of breast feeding while taking propylthiouracil
93. Thyroid autoimmunity and abortion: A prospective study in women undergoing in vitro fertilization
94. The role of thyroid stimulating immunoglobulins of Graves' disease in neonatal thyrotoxicosis
95. Postpartum thyroid dysfunction in pregnant TPO -Ab positive women living in an area with mild iodine deficiency - Is iodine supplementation safe?
96. Treating thyrotoxicosis in pregnant or potentially pregnant women
97. Postpartum thyroiditis: An organ specific syndrome which is not associated with a postpartum polycolonal B-cell activation
98. Iodine metabolism in postpartum thyroiditis
99. A long-term follow-up of postpartum thyroiditis
100. The role of complement in the pathogenesis of postpartum thyroiditis. Ultrasound echogenicity and the degree of complement induced thyroid damage
101. Serum thyroglobulin: An early indicator of autoimmune postpartum thyroid disease
102. The role of complement in the pathogenesis of postpartum thyroiditis: Relationship between complement activation and disease presentation and progression
103. The role of complement in the pathogenesis of postpartum thyroiditis
104. Congenital hypothyroidism due to mutations in the sodium/iodide symporter
105. Maternal thyroid peroxidase antibodies during pregnancy: A marker of impaired child development?
106. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy
107. Brief report; congenital hyperthyroidism caused by a mutation in thyrotropin-receptor gene
108. Antithyroid antibodies and the association with non-organ specific antibodies in recurrent pregnancy loss
109. Postpartum thyroiditis and long-term thyroid status: Prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity
110. Transplancental passage of anti-thyroid autoantibodies in a pregnant woman with auto-immune thyroid disease
111. Postpartum thyroid dysfunction in Bangkok: A geographical variation in the prevalence
112. Cancer during pregnancy
113. Lassitude, coldness, and hair changes following pregnancy, and their response to treatment with thyroid extract
114. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin
115. Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy
116. Clinical review 80 management of hyperthyroidism and hypothyroidism in the pregnant woman
117. Biololgy of human pregnancy: Immune modulation (Th1 and Th2 responses in pregnancy)
118. Evidence for reduced Th1 function in normal pregnancy: A hypothesis for the remission of rheumatoid arthritis
119. Qualitative and quantitative analysis of T lymphocytes during normal human pregnancy
120. An innate view of human pregnancy
121. Normal pregnancy and pre-eclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis
122. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1: Th2 cell ratio during normal human pregnancy and pre-eclampsia
123. Constitutively active germline mutation of the thyrotropin receptor gene as a cause of congenital hyperthyroidism
124. Study on nonspecific immunity in pregnant women: Increased chemiluminescence response of peripheral blood phagocytes
125. Development of postpartum spontaneously resolving transient Graves' hyperthyroidism followed immediately by transient hypothyroidism
126. Presence of thyroid antibodies in early reproductive failure: Biochemical versus clinical pregnancies
127. Postpartum thyroid dysfunction: A frequently undiagnosed endocrine disorder
128. Maternal iodine status and thyroid volume during pregnancy: Correlation with neonatal iodine intake
129. The role of cytokines in depressive illness
130. Postpartum thyroiditis
131. Prospective sutdy of lymphocyte-initiated immunosuppression in normal pregnancy: Evidence of a T-cell etiology for postpartum thyroid dysfunction
132. Thyroxine requirement during pregnancy for replacement therapy of hypothyroidism
133. Gestational transient hyperthyrotoxinaemia (GTH) screening for thyroid function in 23, 163 pregnant women using dried blood spots
134. Pathogenic role of asialo human chorionic gonadotropin in gestational thyrotoxicosis
135. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy
136. Maternal hypothyroxinaemia during the first half of gestation in an iodine deficient area with endemic cretinism and related disorders
137. Genetic defects in thyroid hormone supply
138. Prevalence and characteristics of post-partum thyroid dysfunction: Results of a survey from Toronto, Canada
139. Thyrotoxic storm
140. Insulin-dependent diabetes mellitus and postpartum thyroiditis: An important association (editorial: Comment)
141. The immunology of pregnancy
142. Thyroid antibody titer and avidity in patients with recurrent miscarriage
143. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy
144. Cytokines
145. A case of neonatal McCune-Albright syndrome with Cushing syndrome and hyperthyroidism
146. Mechanism of thyroid stimulation by human chorionic gonadotropin in sera of normal pregnant women
147. Characteristics and clinical correlates of a novel thyroid-stimulating autoantibody
148. 131I therapy
149. Fetal and neonatal hyperthyroidism